164 related articles for article (PubMed ID: 1382909)
1. Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Mehta SP; Sobczyk W; Coyle PK; Sersen EA; Wisniewski HM
Clin Immunol Immunopathol; 1992 Oct; 65(1):53-9. PubMed ID: 1382909
[TBL] [Abstract][Full Text] [Related]
2. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Patrick BA; Sobczyk W; Wisniewski HM
J Neurol Sci; 1992 May; 109(1):64-8. PubMed ID: 1381411
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of interleukin-1beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Mehta SP; Coyle PK; Wisniewski HM
J Infect Dis; 1997 Mar; 175(3):689-92. PubMed ID: 9041345
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal production of measles-specific IgA in subacute sclerosing panencephalitis.
Visudtibhan A; Mehta PD; Kulczycki J; Coyle PK; Thormar H
Acta Neurol Scand; 1997 Aug; 96(2):97-100. PubMed ID: 9272185
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
J Neuroimmunol; 1990 Jul; 28(2):97-109. PubMed ID: 2113934
[TBL] [Abstract][Full Text] [Related]
6. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
7. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea.
Ichiyama T; Siba P; Suarkia D; Reeder J; Takasu T; Miki K; Maeba S; Furukawa S
Cytokine; 2006 Jan; 33(1):17-20. PubMed ID: 16413199
[TBL] [Abstract][Full Text] [Related]
8. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
Gupta E; Dar L; Singh S; Behari M; Broor S
Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid IgG changes in subacute sclerosing panencephalitis in the various stages of the disease and during isoprinosine therapy.
Poloni M; Rocchelli B; Lanzi G; Rosano Burgio F; Besana D
Ital J Neurol Sci; 1981 May; 2(2):177-84. PubMed ID: 6174478
[TBL] [Abstract][Full Text] [Related]
10. Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis.
Patrick BA; Mehta PD; Sobczyk W; Kulczycki J; Woyciechowska-Camenga J; Camenga D; Thormar H
J Neuroimmunol; 1990 Jan; 26(1):69-74. PubMed ID: 2294143
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols.
Haspolat S; Anlar B; Köse G; Coskun M; Yegin O
J Child Neurol; 2001 Jun; 16(6):417-20. PubMed ID: 11417607
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
14. Improvement of SSPE by intrathecal infusion of alpha-IFN.
Kurata T; Matsubara E; Yokoyama M; Nagano I; Shoji M; Abe K
Neurology; 2004 Jul; 63(2):398-9. PubMed ID: 15277654
[No Abstract] [Full Text] [Related]
15. Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis.
Dhib-Jalbut S; McFarland HF; Mingioli ES; Sever JL; McFarlin DE
J Virol; 1988 Jul; 62(7):2483-9. PubMed ID: 3373575
[TBL] [Abstract][Full Text] [Related]
16. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis.
Mattson DH; Roos RP; Arnason BG
Ann Neurol; 1981 Jan; 9(1):34-41. PubMed ID: 6163394
[TBL] [Abstract][Full Text] [Related]
17. Isoprinosine in subacute sclerosing panencephalitis.
Huttenlocher PR; Mattson RH
Neurology; 1979 Jun; 29(6):763-71. PubMed ID: 88024
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.
Anlar B; Guven A; Köse G; Okur H; Kose O; Aydin OF; Kabakus N; Altunbasak S; Herguner O; Sonmez M; Serdaroglu A
J Neuroimmunol; 2005 Jun; 163(1-2):195-8. PubMed ID: 15885323
[TBL] [Abstract][Full Text] [Related]
19. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis.
Saruhan-Direskeneli G; Gürses C; Demirbilek V; Yentür SP; Yilmaz G; Onal E; Yapici Z; Yalçinkaya C; Cokar O; Akman-Demir G; Gökyiğit A
Cytokine; 2005 Oct; 32(2):104-10. PubMed ID: 16226466
[TBL] [Abstract][Full Text] [Related]
20. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
